Ā | Normal (ā¤ā0.5) | Some liver damage (0.5ā0.7) | Significant fibrosis (0.7ā1) | Cirrhosis (ā„ā1) | |||
---|---|---|---|---|---|---|---|
Number (%) | Number (%) | p-value | Number (%) | p-value | Number (%) | p-value | |
Overall | 103,678 | 444 | Ā | 256 | Ā | 253 | Ā |
Sex | Ā | Ā | ā<ā0.001 | Ā | ā<ā0.001 | Ā | 0.004 |
āFemale | 57,004 (55.0) | 194 (43.7) | Ā | 105 (41.0) | Ā | 116 (45.8) | Ā |
āMale | 46,674 (45.0) | 250 (56.3) | Ā | 151 (59.0) | Ā | 137 (54.2) | Ā |
Age | Ā | Ā | ā<ā0.001 | Ā | ā<ā0.001 | Ā | ā<ā0.001 |
ā18ā39 | 2,164 (2.1) | 12 (2.7) | Ā | 7 (2.7) | Ā | 8 (3.2) | Ā |
ā40ā64 | 44,341 (42.8) | 254 (57.3) | Ā | 159 (62.4) | Ā | 147 (58.1) | Ā |
ā65ā74 | 34,941 (33.7) | 114 (25.7) | Ā | 56 (22.0) | Ā | 61 (24.1) | Ā |
āāā„ā75 | 22,134 (21.4) | 63 (14.2) | Ā | 33 (12.9) | Ā | 37 (14.6) | Ā |
BMI (kg/m^2) | Ā | Ā | 0.031 | Ā | 0.176 | Ā | 0.002 |
āā<ā18.5 | 985 (1.0) | 8 (1.8) | Ā | 3 (1.2) | Ā | 3 (1.2) | Ā |
ā18.5ā29.9 | 19,443 (18.8) | 100 (22.5) | Ā | 60 (23.4) | Ā | 72 (28.5) | Ā |
ā30ā34.9 | 33,962 (32.8) | 123 (27.7) | Ā | 89 (34.8) | Ā | 80 (31.6) | Ā |
ā35ā39.9 | 41,564 (40.1) | 176 (39.6) | Ā | 90 (35.2) | Ā | 84 (33.2) | Ā |
āāā„ā40 | 7,726 (7.5) | 37 (8.3) | Ā | 14 (5.5) | Ā | 14 (5.5) | Ā |
Functional Status Prior to Surgery | Ā | Ā | 0.865 | Ā | ā<ā0.001 | Ā | 0.120 |
āDependent | 2,222 (2.1) | 9 (2.0) | Ā | 17 (6.7) | Ā | 9 (3.6) | Ā |
āIndependent | 101,181 (97.9) | 434 (98.0) | Ā | 237 (93.3) | Ā | 243 (96.4) | Ā |
Frailty | Ā | Ā | 0.923 | Ā | 0.457 | Ā | 0.813 |
āā<ā2 | 102,223 (98.6) | 438 (98.6) | Ā | 251 (98.0) | Ā | 249 (98.4) | Ā |
āāā„ā2 | 1,457 (1.4) | 6 (1.4) | Ā | 5 (2.0) | Ā | 4 (1.6) | Ā |
ASA classification | Ā | Ā | ā<ā0.001 | Ā | 0.004 | Ā | ā<ā0.001 |
āāā¤ā2 | 54,372 (52.4) | 165 (37.2) | Ā | 111 (43.4) | Ā | 83 (32.8) | Ā |
āāā„ā3 | 49,308 (47.6) | 279 (62.8) | Ā | 145 (56.6) | Ā | 170 (67.2) | Ā |
Smoker | Ā | Ā | ā<ā0.001 | Ā | ā<ā0.001 | Ā | ā<ā0.001 |
āNo | 90,397 (87.2) | 344 (77.5) | Ā | 186 (72.7) | Ā | 190 (75.1) | Ā |
āYes | 13,283 (12.8) | 100 (22.5) | Ā | 70 (27.3) | Ā | 63 (24.9) | Ā |
Steroid use | Ā | Ā | 0.829 | Ā | 0.392 | Ā | 0.564 |
āNo | 98,784 (95.3) | 424 (95.5) | Ā | 241 (94.1) | Ā | 243 (96.0) | Ā |
āYes | 4,896 (4.7) | 20 (4.5) | Ā | 15 (5.9) | Ā | 10 (4.0) | Ā |
Comorbidities | |||||||
āHTN | 60,670 (58.5) | 269 (60.6) | 0.385 | 138 (53.9) | 0.144 | 144 (56.9) | 0.606 |
āCHF | 536 (0.5) | 4 (0.9) | 0.299 | 2 (0.8) | 0.382 | 1 (0.4) | 1.000 |
āDiabetes Mellitus | 13,968 (13.5) | 75 (16.9) | 0.035 | 43 (16.8) | 0.120 | 37 (14.6) | 0.592 |
āCOPD | 4,634 (4.5) | 25 (5.6) | 0.238 | 12 (4.7) | 0.879 | 14 (5.5) | 0.363 |
āBleeding Disorder | 2,701 (2.6) | 58 (13.1) | ā<ā0.001 | 34 (13.3) | ā<ā0.001 | 42 (16.6) | ā<ā0.001 |